114 related articles for article (PubMed ID: 11724109)
1. Peripheral edema associated with mirtazapine.
Kutscher EC; Lund BC; Hartman BA
Ann Pharmacother; 2001 Nov; 35(11):1494-5. PubMed ID: 11724109
[No Abstract] [Full Text] [Related]
2. Mirtazapine-associated peripheral oedema.
Lai FY; Shankar K; Ritz S
Aust N Z J Psychiatry; 2016 Nov; 50(11):1108. PubMed ID: 27687778
[No Abstract] [Full Text] [Related]
3. Mirtazapine associated tender pitting pedal oedema.
Saddichha S
Aust N Z J Psychiatry; 2014 May; 48(5):487. PubMed ID: 24285564
[No Abstract] [Full Text] [Related]
4. [Edema tendency, dyspnea and hypertension in the treatment with mirtazapine (Remeron)].
Jensen JB
Ugeskr Laeger; 1999 May; 161(18):2699. PubMed ID: 10434798
[No Abstract] [Full Text] [Related]
5. Vitamin B6 treatment of oedema induced by mirtazapine and isocarboxazid.
Larsen JK; Bendsen BB; Bech P
Acta Psychiatr Scand; 2011 Jul; 124(1):76-7; discussion 77. PubMed ID: 21410439
[No Abstract] [Full Text] [Related]
6. Mirtazapine-induced akathisia.
Girishchandra BG; Johnson L; Cresp RM; Orr KG
Med J Aust; 2002 Mar; 176(5):242. PubMed ID: 11999246
[No Abstract] [Full Text] [Related]
7. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
8. Acute reversible dyskinesia induced by mirtazapine.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
[No Abstract] [Full Text] [Related]
9. Mirtazapine: unable to induce serotonin toxicity?
Gillman PK
Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
[No Abstract] [Full Text] [Related]
10. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
Isbister GK; Whyte IM
Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
[No Abstract] [Full Text] [Related]
11. Subclinical pancreatitis related to mirtazapine - a case report.
Sommer M; Dieterich A; Krause C; Rüther E; Wiltfang J
Pharmacopsychiatry; 2001 Jul; 34(4):158-9. PubMed ID: 11518479
[No Abstract] [Full Text] [Related]
12. Lack of sexual adverse effects with mirtazapine.
Farah A
Am J Health Syst Pharm; 1998 Oct; 55(20):2195-6. PubMed ID: 9812164
[No Abstract] [Full Text] [Related]
13. Mirtazapine overdose with benign outcome.
Raja M; Azzoni A
Eur Psychiatry; 2002 Apr; 17(2):107. PubMed ID: 11973120
[No Abstract] [Full Text] [Related]
14. A case of mirtazapine-associated hair loss.
Lin CH; Hsu CW; Lin CH; Lane HY
J Clin Psychiatry; 2010 Oct; 71(10):1400-1. PubMed ID: 21062618
[No Abstract] [Full Text] [Related]
15. Possible mirtazapine-induced rhabdomyolysis.
Khandat AB; Nurnberger JI; Shekhar A
Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213
[No Abstract] [Full Text] [Related]
16. Mirtazapine associated with drug-related thrombocytopenia: a case report.
Stuhec M; Alisky J; Malesic I
J Clin Psychopharmacol; 2014 Oct; 34(5):662-4. PubMed ID: 25118079
[No Abstract] [Full Text] [Related]
17. [Arthralgia associated with mirtazapine].
Veyrac G; Brachet V; Rocher S; Bourin M; Jolliet P
Therapie; 2000; 55(5):652-5. PubMed ID: 11201983
[No Abstract] [Full Text] [Related]
18. Mirtazapine-induced arthralgia and coagulopathy: a case report.
Demet MM; Mizrak S; Esen-Danaci A
J Clin Psychopharmacol; 2005 Aug; 25(4):395-6. PubMed ID: 16012290
[No Abstract] [Full Text] [Related]
19. Use of mirtazapine as prophylactic treatment for migraine headache.
Brannon GE; Rolland PD; Gary JM
Psychosomatics; 2000; 41(2):153-4. PubMed ID: 10749956
[No Abstract] [Full Text] [Related]
20. Mirtazapine-induced hepatotoxicity.
Hui CK; Yuen MF; Wong WM; Lam SK; Lai CL
J Clin Gastroenterol; 2002 Sep; 35(3):270-1. PubMed ID: 12192206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
